3 Stocks for Growth-Oriented Investors

11:56am, Tuesday, 04'th May 2021
The three stocks listed below could be of interest to growth-oriented investors, as their price-earnings ratios are below 20 while their trailing 12-month earnings per share increased significantly ov
Hologic Inc (NASDAQ: HOLX) posted second-quarter results that trailed the consensus forecast; however, the company tried to provide some cushion with a better third-quarter fueled by COVID-19 test
Hologic, Inc. (HOLX) CEO Stephen MacMillan on Q2 2021 Results - Earnings Call Transcript
Hologic (HOLX) delivered earnings and revenue surprises of -1.15% and -0.40%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of Hologic Inc. fell nearly 7% in the extended session Tuesday after the medical technology company missed Wall Street expectations for its adjusted profit in the fiscal second quarter and quar

Recap: Hologic Q2 Earnings

04:50pm, Wednesday, 28'th Apr 2021
Shares of Hologic (NASDAQ:HOLX) fell in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 354.39% year over year to $2.59, which missed the estimat
Hologic (HOLX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.
Strength in Molecular Diagnostics business is likely to have continued to aid Hologic's (HOLX) performance in the second quarter of fiscal 2021.
Here we discuss three MedTech subsectors, which encourage us with their consistency through the pandemic year and are likely to have continued with their winning streak in Q121.
Hologic (HOLX) is likely to have gained during fiscal second-quarter 2021 on the back of robust performances of its business arms despite coronavirus-led economic doldrums.
Hologic (HOLX) closed the most recent trading day at $76.68, moving +0.03% from the previous trading session.
Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Hologic (HOLX) closed at $74.38 in the latest trading session, marking a +1.02% move from the prior day.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE